placeholder image
S. Genuth All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Insulin dose and cardiovascular mortality in the ACCORD Trial. 
    Diabetes care. 2015
  • Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. 
    Kidney International. 2012
  • Long-term effects of intensive glucose lowering on cardiovascular outcomes. 
    New England Journal of Medicine. 2011
  • Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. 
    Lancet (London, England). 2010
  • Effects of medical therapies on retinopathy progression in type 2 diabetes. 
    New England Journal of Medicine. 2010
  • The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. 
    BMJ (Clinical research ed.). 2010
  • Effects of intensive glucose lowering in type 2 diabetes. 
    New England Journal of Medicine. 2008
  • Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods Am J Cardiol
    2007
  • Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Am J Cardiol
    2007
  • Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. 
    New England Journal of Medicine. 2003
    • Abstract
  • Microvascular effects of intensive blood pressure control and its relation to glycaemic control in the ACCORD blood pressure trial [abstract]. 
    Diabetologia. 2011
    • presentations
    Contact
    full name
  • S. Genuth
  • S Genuth
    • Quick Info
     
    Collaboration